Food and Drug Administration-American Urological Association-Society of Urologic Oncology Workshop on Partial Gland Ablation for Prostate Cancer; Public Workshop

Riepilogo

The Food and Drug Administration (FDA) is announcing the following public workshop entitled "AUA-FDA-SUO Workshop on Partial Gland Ablation for Prostate Cancer." The topics to be discussed are the technologies and imaging used in partial gland ablation, and the design of clinical trials to measure the most appropriate endpoints for partial gland ablation for prostate cancer. The workshop will be part of the American Urological Association (AUA) annual meeting in New Orleans, LA.